REQUEST A DEMO
Total
USD $0.00
Search more companies

Sindan - Pharma SRL (Romania)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sindan - Pharma SRL Profile Updated: February 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sindan - Pharma SRL is an enterprise based in Romania. Its main office is in Bucharest. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on February 06, 2003. There was a net sales revenue drop of 11.91% reported in Sindan - Pharma SRL’s latest financial highlights for 2024. Its’ total assets recorded a negative growth of 8.12%. In 2024, Sindan - Pharma SRL’s net profit margin increased by 2.48%.

Headquarters
Bulevardul Ion Mihalache Nr. 11
Bucharest; Bucharest;

Contact Details: Purchase the Sindan - Pharma SRL report to view the information.

Basic Information
Registered Capital:
Purchase the Sindan - Pharma SRL report to view the information.
Financial Auditors:
Purchase the Sindan - Pharma SRL report to view the information.
Incorporation Date:
February 06, 2003
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sindan - Pharma SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-11.91%
Total Operating Revenue
-11.74%
Operating Profit
10.83%
EBITDA
5.75%
Net Profit/Loss for the Period
20.42%
Total Assets
-8.12%
Total Equity
-7.58%
Operating Profit Margin
1.84%
Net Profit Margin
2.48%
Return on Equity (ROE)
2.64%
Quick Ratio
-0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?